Inpatient Self Monitoring and Administration Study (ISMAS)

Not Applicable

• Conditions: Diabetes Mellitus; Hyperglycemia; Hypoglycemia
• Interventions: Procedure: Self blood glucose monitoring and insulin administration; Procedure: Standard care

• Registration Number: NCT00506272
• Lead Sponsor: Atlanta VA Medical Center

Brief Summary

ISMAS is designed to test the hypothesis that self management of insulin dependent diabetes mellitus by selected patients admitted for elective surgery is more efficacious than standard care with respect to overall glycemic control, attaining finger-stick blood sugars, and administering insulin.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-07-23
• Study First Submitted QC: 2007-07-23
• Study First Posted: 2007-07-25
• Study Start: 2007-12
• Status Verified: 2015-12
• Last Update Submitted: 2015-12-11
• Last Update Posted: 2015-12-14
• Primary Completion: 2016-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Patient administered care	Self blood glucose monitoring and insulin administration	Patients will self-monitor and record finger-stick blood glucose measurements, and self administer insulin at doses agreed upon with the consulting endocrinology in-patient service.
Standard care	Standard care	Patients admitted for elective surgery will receive standard diabetes care, including but not limited to finger stick blood glucose determinations, and insulin injections delivered by the nursing staff.

Primary Outcome Measures

Name	Time	Method
number of blood glucose measurements obtained/number of blood glucose measurements ordered	patients will be followed for the duration of hospital stay, an expected average of 5 days
number of insulin doses administered/number of insulin doses prescribed	patients will be followed for the duration of hospital stay, an expected average of 5 days
average blood glucose	patients will be followed for the duration of hospital stay, an expected average of 5 days

Trial Locations

Locations (1)

Atlanta VA Medical Center; 🇺🇸 Decatur, Georgia, United States